Animal studies also demonstrate its ability to reduce seizure threshold, alleviate depression-like behaviors, and modulate dopaminergic and serotonergic systemseven showing synergy with antidepressants and anxiolytics in preclinical models
Research has explored its role in cellular growth signaling, differentiation pathways, and IGF-1 receptor interaction mechanisms in laboratory models
GLP-1 users who kept THEIR HAIR
This translates into $126 billion in sales by 2029, a 2023-2029 sales CAGR of 30%
YOUR PATH FORWARD What's Next Wegovy Coverage: Other Major Insurers See how other insurers compare on Wegovy coverage: Blue Cross Blue Shield Major 2026 coverage restrictions announced Cigna Often covers with step therapy requirements Aetna Most plans cover with prior authorization Anthem Blue Cross Separate policies from other BCBS affiliates Humana Coverage varies
The long-term weight loss effect of GLP-1RAs has also been validated in a recent large-scale clinical trial, which reported a weight loss up to 20.9% after 72-week treatment of tirzepatide [22]
-1775582746855.png)
